Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-05-23 @ 9:14 AM
Study NCT ID:
NCT00460850
Status:
TERMINATED
Last Update Posted:
2008-06-30
First Post:
2007-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis B, Chronic | View |
Keywords: